AI Cure is a research tool showing open data. Not medical advice. Discuss with your doctor. Terms

โ† Trials
๐Ÿงช

POLish Registry of CArdioneuroablation and CArdioneuromodulation

Recruitingn/aAges 18 Years - anyAllSABAMED Medical Center Ltd.
๐Ÿ’ฌ

In plain words

What the trial is, and whether it could suit you

The multicentre observational study POL-CA involves a wide spectrum of patients with a history of syncopy. The study recruits patients with diagnosed vasovagal syndrome, cardioinhibitory carotid sinus syndrome, symptomatic sinus bradycardia or atrioventricular block, postural orthostatic tachycardia syndrome, orthostatic hypotension, and inappropriate sinus tachycardia syndrome. This is an observational, controlled study with retrospective, clinical data analysis of previously treated patients and the analysis of syncopal patients prospectively recruited into the study. The aim of the POL-CA registry is to create a platform for physicians to record treatment data for patients undergoing procedures that affect innervation or modify cardiovascular reflexes (cardioneuroablation, cardioneuromodulation) in order to provide a multicentre summary of population characteristics and treatment outc

Sign in to get the eligibility rules as simple questions to take to your doctor.

๐Ÿ“‹ Eligibility rules (as published)
Inclusion Criteria: * Age โ‰ฅ 18 years * Diagnosis of at least one of the following conditions: * Inappropriate sinus tachycardia (IST) * Postural orthostatic tachycardia syndrome (POTS) * Vasovagal syncope (VVS) * Cardioinhibitory carotid sinus syndrome (CSS) * Symptomatic sinus bradycardia or functional AV block * Orthostatic hypotension (OH) * History of recurrent autonomic symptoms (e.g., syncope, bradycardia, palpitations, orthostatic intolerance) * Undergoing or previously underwent interventional treatment affecting cardiac autonomic innervation (e.g., cardioneuroablation, SN-sparing ablation, cardiac sympathetic denervation) * Provided written informed consent (for prospective arm) Exclusion Criteria: * Structural heart disease requiring surgical intervention * Permanent pacemaker or ICD implanted prior to enrollment * Inability to complete follow-up assessments or questionnaires * Severe psychiatric comorbidities impairing participation * Participation in another interventional clinical trial
๐Ÿ’Š

What it tests

  • cardioneuroablation
  • SN sparing hybrid ablation
  • Cardiac sympathetic denervation
  • Hybrid Cardiac Rehabilitation Program
  • Transcutaneous Vagus Nerve Stimulation (tVNS)
๐Ÿ“

Where

1 site
SabaMed
Rzeszรณw, Poland
๐Ÿค Taking part is your choice, and you can leave at any time. Only the trial team can confirm you are eligible โ€” always decide together with your own doctor.
๐Ÿ›ก๏ธ

AI Cure shows public evidence (Open Targets, ClinicalTrials.gov, PubMed, openFDA, DepMap, AlphaFold) with its source, and AI summaries that cite it โ€” not medical advice and not a cure. Treatment decisions belong with your doctor. Research ideas are shared only with approved researchers and labs, who can test them. In an emergency call your local emergency number (112 in India and Europe, 911 in the US). AI Cure Terms of Use ยท Privacy